After its crucial activity in promoting malignant progression in cancer cells was initially demonstrated [10, 11], increased FABP5 expression in archival prostate cancer tissues is found to be significantly associated with a reduced patient survival time. This evidence concerns the gene FABP5 and prostate carcinoma.